Campbell Shane Alden has filed 5 insider transactions across 1 company since May 2025.
Most recent transaction: a grant/award of 1131 shares of WEST PHARMACEUTICAL SERVICES INC ($WST) on March 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | WEST PHARMACEUTICAL SERVICES INC | $WST | Campbell Shane Alden | SVP, Proprietary Segment | A | Rst. Stock Unit | 1131 | $0.00 | 1,131.0000 | 72,700,000 | 9999.99% | 0.00% |
| March 1, 2026 | WEST PHARMACEUTICAL SERVICES INC | $WST | Campbell Shane Alden | SVP, Proprietary Segment | A | Stock Option (Right to Buy) | 2691 | $0.00 | 2,691.0000 | 72,700,000 | 9999.99% | 0.00% |
| May 12, 2025 | WEST PHARMACEUTICAL SERVICES INC | $WST | Campbell Shane Alden | SVP, Proprietary Segment | A | Rst. Stock Unit | 1891 | $0.00 | 1,891.0000 | 73,700,000 | 9999.99% | 0.00% |
| May 12, 2025 | WEST PHARMACEUTICAL SERVICES INC | $WST | Campbell Shane Alden | SVP, Proprietary Segment | A | Rst. Stock Unit | 1182 | $0.00 | 1,182.0000 | 73,700,000 | 9999.99% | 0.00% |
| May 12, 2025 | WEST PHARMACEUTICAL SERVICES INC | $WST | Campbell Shane Alden | SVP, Proprietary Segment | A | Stock Options (Right to Buy) | 2852 | $219.46 | 2,852.0000 | 73,700,000 | 9999.99% | 0.00% |